Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Emerging Drug Trends
    • Illegal Online Pharmacies
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (90)
  • 2025 (72)

Subject

  • Drug Trafficking (1384)
  • Synthetic drugs (477)
  • Arrests/Convictions - Major (380)
  • Guns/Weapons (346)
  • Fake Pills (283)
  • Seizures (Drugs/Property) (199)
  • Guilty Plea (198)
  • OCDETF/Task Force (192)
  • Fentanyl Free America (152)
  • Fentanyl Awareness (143)
  • Prescription Drugs (114)
  • Counterfeit Pills (111)
  • Task Forces/Task Force Officers (101)
  • Major Law Enforcement Operation (94)
  • Money Laundering (76)
  • Overdose (74)
  • Take Back Day (66)
  • One Pill Can Kill (57)
  • Pharmaceuticals/Pharmacists/Physicians (56)
  • Gangs (53)
  • HIDTA (32)
  • Other (32)
  • Cartel (30)
  • Campaigns (29)
  • Press Conferences (25)
  • Extraditions (24)
  • Narcoterrorism (23)
  • Prevention/Education - DEA websites GSAD, JTT etc (20)
  • Homeland Security Task Force (HSTF) (16)
  • Terrorism (11)
  • International/Foreign Operations (10)
  • Public and Media Affairs - also see Congressional Affairs (10)
  • Dark Web- Internet Trafficking (8)
  • Critical Incident (5)
  • Asset Forfeiture (4)
  • Intelligence Division - Intelligence Products (4)
  • Red Ribbon (3)
  • Intergovernmental Affairs (2)
  • Museum and Visitors Center (2)
  • Forensics: Quality Management System Documents (1)
  • Diversion Division (97)
  • Outreach/Drug Prevention (71)
  • Forensics (1)

Drug Name

  • Fentanyl (29)
  • Oxycodone (10)
  • Hydromorphone (6)
  • Benzodiazepines (5)
  • Amphetamines (4)
  • Cocaine (3)
  • Heroin (3)
  • Methamphetamine (3)
  • Opioids (3)
  • Ecstasy/MDMA (1)
  • GHB (1)
  • Marijuana (Cannabis) (1)
  • Marijuana Concentrates (1)
  • Morphine (1)
  • Xylazine (1)

Field Division

  • Atlanta (4)
  • Chicago (4)
  • Dallas (3)
  • Detroit (2)
  • El Paso (8)
  • Houston (8)
  • Los Angeles (3)
  • Louisville (3)
  • Miami (6)
  • New England (14)
  • New Jersey (3)
  • New Orleans (2)
  • New York (8)
  • Omaha (20)
  • Phoenix (5)
  • Rocky Mountain (7)
  • San Antonio (1)
  • San Diego (1)
  • San Francisco (12)
  • Seattle (11)
  • Sede (15)
  • St. Louis (14)
  • Tampa (1)
  • Washington, DC (7)
Clear All Results
View Archived Press Releases
162 Results - Showing 1 to 10
PRESS RELEASE

Houston Felon Convicted of Trafficking Methamphetamine and Possessing Firearm

HOUSTON – A 46-year-old man has been convicted of possession with intent to distribute methamphetamine and unlawful possession of a firearm by a convicted felon. A federal jury deliberated for approximately two hours before convicting Eduardo Nevares Oct. 8 following a two-day trial.At trial, the jury heard that law enforcement...
PRESS RELEASE

DEA Hosts the 31st National Prescription Drug Take Back Day on Saturday, October 24th

SEATTLE – The U.S. Drug Enforcement Administration, in collaboration with more than 4,300 law enforcement partners, will host the 31st National Prescription Drug Take Back Day on Saturday, October 24, from 10 a.m. to 2 p.m. The DEA Seattle Field Division is working with more than 90 law enforcement partners...
PRESS RELEASE

CVS Agrees to Pay $315M for Illegally Filling Unlawful Opioid Prescriptions and for Submitting False Claims to the Federal Government

CVS Pharmacy Inc., a Rhode Island-based pharmacy chain, and its related corporate entities (collectively, CVS) have agreed to pay $315 million to resolve allegations that, from October 17, 2013 through December 2, 2025, CVS illegally filled prescriptions for opioids and other controlled substances in violation of the Controlled Substances Act...
PRESS RELEASE

Washington, DC Man Sentenced for Role in Multi-State Pharmacy Burglaries

Baltimore, Maryland – A Washington, DC, man received a federal-prison term, today, in connection with a conspiracy to commit burglaries of multiple pharmacies spanning three different states. U.S. District Judge Stephanie Gallagher sentenced Deontae Britton, aka Deaundre Blount, to 80 months in prison, followed by three years of supervised release...
PRESS RELEASE

DEA to Host 31st National Prescription Drug Take Back Day on Saturday, October 24th

WASHINGTON, DC –The U.S. Drug Enforcement Administration, in collaboration with more than 4,300 law enforcement partners, will host the 31st National Prescription Drug Take Back Day on Saturday, October 24, from 10 a.m. to 2 p.m. More than 4,400 collection sites will be set up across the country to dispose...
PRESS RELEASE

Former Connecticut Resident Guilty of Operating Websites to Illegally Sell Misbranded and Unapproved Drugs

NEW HAVEN, Conn. - David X. Sullivan, United States Attorney for the District of Connecticut, announced that on September 18, 2026, a federal jury in New Haven found RYAN FIELDS, 52, of Port Neches, Texas, guilty of federal offenses related to illegally selling misbranded and unapproved prescription drugs. According to...
PRESS RELEASE

Pharmacist Pleads Guilty To Drug Diversion From National Pharmacy Chain

BOSTON – A Pittsfield pharmacist pleaded guilty in federal court in Boston to diverting Adderall and Dextroamp-amphetamin (generic Adderall) from a national pharmacy chain. Joshua Bradley, 30, of Pittsfield, pleaded guilty to five counts of acquiring a controlled substance by fraud, deception and subterfuge. U.S. Senior District Court Judge William...
PRESS RELEASE

Wisconsin Doctor Sentenced to Federal Prison for Unlawful Prescribing

MILWAUKEE -- U.S. District Judge Lynn Adelman sentenced Jerry Jones III, 69, a former emergency room physician from Mequon, Wisconsin, to 27 months’ imprisonment on Oct. 1, 2026, announced Brad D. Schimel, First Assistant United States Attorney for the Eastern District of Wisconsin. On June 29, 2026, Jones pleaded guilty...
PRESS RELEASE

DEA Highlights the Integral Role of Forensic Science in Addressing the Synthetic Drug Crisis

SAN FRANCISCO — As synthetic drugs continue to evolve and threaten American lives, DEA chemists and forensic science professionals play an essential role in helping the U.S. Drug Enforcement Administration identify emerging threats, connect evidence to investigations, and provide timely information that can save lives. From analyzing suspected fentanyl and...
PRESS RELEASE

DEA Highlights the Integral Role of Forensic Science in Addressing the Synthetic Drug Crisis

WASHINGTON, D.C. — As synthetic drugs continue to evolve and threaten American lives, DEA chemists and forensic science professionals play an essential role in helping the U.S. Drug Enforcement Administration identify emerging threats, connect evidence to investigations, and provide timely information that can save lives. From analyzing suspected fentanyl and...

Paginación

  • Current page 1
  • Página 2
  • Página 3
  • Página 4
  • Página 5
  • Página 6
  • Página 7
  • Página 8
  • Página 9
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster